390 related articles for article (PubMed ID: 12682303)
1. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
Gray PC; Harrison CA; Vale W
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
[TBL] [Abstract][Full Text] [Related]
2. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
[TBL] [Abstract][Full Text] [Related]
3. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
4. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.
Harrison CA; Gray PC; Fischer WH; Donaldson C; Choe S; Vale W
J Biol Chem; 2004 Jul; 279(27):28036-44. PubMed ID: 15123686
[TBL] [Abstract][Full Text] [Related]
5. Cell-type specific regulation of myostatin signaling.
Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
[TBL] [Abstract][Full Text] [Related]
6. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
[TBL] [Abstract][Full Text] [Related]
7. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277
[TBL] [Abstract][Full Text] [Related]
8. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
[TBL] [Abstract][Full Text] [Related]
9. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
10. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.
Harms PW; Chang C
Genes Dev; 2003 Nov; 17(21):2624-9. PubMed ID: 14563676
[TBL] [Abstract][Full Text] [Related]
11. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
12. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
13. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
Yeo C; Whitman M
Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
[TBL] [Abstract][Full Text] [Related]
14. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Reissmann E; Jörnvall H; Blokzijl A; Andersson O; Chang C; Minchiotti G; Persico MG; Ibáñez CF; Brivanlou AH
Genes Dev; 2001 Aug; 15(15):2010-22. PubMed ID: 11485994
[TBL] [Abstract][Full Text] [Related]
15. Identification of a functional binding site for activin on the type I receptor ALK4.
Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
[TBL] [Abstract][Full Text] [Related]
16. Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis.
Torres PB; Florio P; Galleri L; Reis FM; Borges LE; Petraglia F
Reprod Sci; 2009 Aug; 16(8):727-33. PubMed ID: 19386982
[TBL] [Abstract][Full Text] [Related]
17. Cripto localizes Nodal at the limiting membrane of early endosomes.
Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
[TBL] [Abstract][Full Text] [Related]
18. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
[TBL] [Abstract][Full Text] [Related]
19. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
20. Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development.
Andersson O; Bertolino P; Ibáñez CF
Dev Biol; 2007 Nov; 311(2):500-11. PubMed ID: 17936261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
